-
Pioglitazone and heart disease; ARBs manufacturers spend millions to show the non-inferiority of their products compared to less expensive, generic ACE inhibitors; some athletes turn to growth hormone because it is difficult to detect; FDA Actions
-
Most of us dread the chief complaint of weakness. This nonspecific symptom engenders a differential that ranges from malingering to fatal, from psychiatric to cancer. The finding of demonstrable muscle weakness helps, but then leads to a confusing set of relatively rare diagnoses.
-
FDA drug approval to change? Urinary incontinence in women; how metabolism of certain drugs can be predicted by genetic analysis; bowel preps may compromise renal function especially in the elderly according to a new study; FDA Actions.
-
Chronic wounds represent a significant portion of the complaints seen by physicians, especially in the primary care setting. Visits for wound care account for just over 2% of all visits to office-based physicians in the United States.
-
Does erythropoietin worsen cancer death rates? Most hypothyroid patients can be replaced with levothyroxine alone without additional T3. Does aggressive control in type 2 diabetes save lives?
-
In this edition of Primary Care Reports, we will only examine the role of depression and its effect on cardiovascular disease (CVD). We will also explore the recommended pharmacological approach for the treatment of depression when these two syndromes are comorbid.
-
Stop smoking drug Chantix rates stronger warning from FDA; Type 2 diabetes surgery on the way?; Vytorin study inconclusive; Influenza A virus found resistant to Tamiflu; FDA actions.
-
Most cases of thrombocytopenia seen are expected. Patients are known to have hematological disease or are receiving chemotherapy. At times, however, the physician is confronted with an unexpected laboratory finding in an asymptomatic patient, or with a patient who is bleeding. The challenge, as usual, is to determine the need for acute treatment and the appropriate disposition.
-
The Physician Quality Reporting Initiative (PQRI) is a program by the Centers for Medicare and Medicaid Services (CMS) that affects physicians and other health care providers who participate in Medicare. Clinicians in practically all medical specialties can participate in this voluntary reporting initiative and earn a bonus for satisfactory reporting.
-
